Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, Q2 2026
-9,400
Period ended Jun 30, 2026
Change on a year earlier
-13.0%
-10,800 in Q2 2025
History
59 quarters
Since Q4 2009
Sources
58
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accumulated depreciation ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -9,400 | -13.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | -9,300 | -12.3% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | -11,100 | +6.9% | Form 10-Q (filed 2026-05-01) ↗ |
| Q3 2025 | Sep 30, 2025 | -11,000 | +6.8% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | -10,800 | +6.9% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | -10,600 | +7.1% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | -10,388 | +5.9% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | -10,300 | +6.2% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | -10,100 | +6.3% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -9,900 | +5.3% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | -9,808 | +5.7% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | -9,700 | +5.4% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | -9,500 | +5.6% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | -9,400 | +5.6% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | -9,283 | +5.5% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2022 | Sep 30, 2022 | -9,200 | 0.0% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | -9,000 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | -8,900 | -2.2% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | -8,798 | -2.0% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2021 | Sep 30, 2021 | -9,200 | +4.5% | Form 10-Q (filed 2021-11-03) ↗ |
| Q1 2021 | Mar 31, 2021 | -9,100 | +7.1% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | -8,977 | +7.4% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2020 | Sep 30, 2020 | -8,800 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | -8,700 | +7.4% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | -8,500 | +7.6% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | -8,357 | +7.2% | Form 10-K (filed 2021-02-09) ↗ |
| Q2 2019 | Jun 30, 2019 | -8,100 | +3.8% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | -7,900 | +2.6% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | -7,796 | +2.7% | Form 10-K (filed 2020-02-12) ↗ |
| Q3 2018 | Sep 30, 2018 | -8,000 | +6.7% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | -7,800 | 0.0% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | -7,700 | +1.3% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | -7,590 | +1.7% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | -7,500 | 0.0% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | -7,800 | +4.0% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | -7,600 | +2.7% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | -7,466 | +2.8% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2016 | Sep 30, 2016 | -7,500 | +1.4% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | -7,500 | +2.7% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | -7,400 | +2.8% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | -7,265 | +3.3% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2015 | Sep 30, 2015 | -7,400 | 0.0% | Form 10-Q (filed 2015-11-02) ↗ |
| Q2 2015 | Jun 30, 2015 | -7,300 | +1.4% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | -7,200 | +1.4% | Form 10-Q (filed 2015-04-27) ↗ |
| Q4 2014 | Dec 31, 2014 | -7,033 | +1.3% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2014 | Sep 30, 2014 | -7,400 | +8.8% | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | -7,200 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | -7,100 | +9.2% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | -6,942 | +4.8% | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2013 | Sep 30, 2013 | -6,800 | +6.3% | Form 10-Q (filed 2013-10-29) ↗ |
| Q1 2013 | Mar 31, 2013 | -6,500 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | -6,621 | +13.9% | Form 10-K (filed 2014-02-24) ↗ |
| Q3 2012 | Sep 30, 2012 | -6,400 | – | Form 10-Q (filed 2012-11-06) ↗ |
| Q4 2011 | Dec 31, 2011 | -5,811 | +0.2% | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2011 | Mar 31, 2011 | -5,300 | – | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | -5,800 | +25.1% | Form 10-Q (filed 2012-05-08) ↗ |
| Q3 2010 | Sep 30, 2010 | -5,000 | – | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | -4,900 | – | Form 10-Q (filed 2010-08-09) ↗ |
| Q4 2009 | Dec 31, 2009 | -4,638 | – | Form 10-K (filed 2011-02-25) ↗ |
Cite this data
StockData. (2026). Amgen Accumulated depreciation ($M) ($M), quarterly Q4 2009–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_accum_depr
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.